Is the race to take protein kinase inhibitors to market compromising their success in the clinic?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Engineered multifunctional nanowires as novel biosensing tools for highly sensitive detection
Applied Nanoscience Open Access 04 July 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
*AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, November 17–21, 2003.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Becker, J. Signal transduction inhibitors—a work in progress. Nat Biotechnol 22, 15–18 (2004). https://doi.org/10.1038/nbt0104-15
Issue Date:
DOI: https://doi.org/10.1038/nbt0104-15
This article is cited by
-
Engineered multifunctional nanowires as novel biosensing tools for highly sensitive detection
Applied Nanoscience (2013)
-
A microfluidic platform for sequential ligand labeling and cell binding analysis
Biomedical Microdevices (2007)
-
Fabrication of silicon nanowire devices for ultrasensitive, label-free, real-time detection of biological and chemical species
Nature Protocols (2006)
-
Decompartmentalizing target validation—thinking outside the pipeline boxes
Journal of Molecular Medicine (2006)
-
Multi-kinase inhibitors create buzz at ASCO
Nature Biotechnology (2005)